Tirzepatide (The same active ingredient in Mounjaro® and Zepbound™*)

No, MEDIVA does not require insurance. We offer a straightforward pricing and billing structure, along with affordable generic options, to ensure that managing your health is as easy and accessible as possible.

Most patients in the trial were able to have a 5% weight loss while people who received 10 mg or 15 mg doses demonstrated 20% reduction in body weight.

In the SURPASS-2 trial, the active ingredient in Zepbound medication was found to be superior to semaglutide in regards to the mean change in the glycated hemoglobin level with the added effect of weight reduction.

Absolutely! We understand that circumstances may change, and there are no long-term contracts or cancellation fees involved. We are committed to customer satisfaction.

Our dosage plans are expertly designed to align with your individual weight loss objectives and preferences.

The $299 a month covers doses of 2.5mg-10mg a week

Doses from 12.5mg-15mg a week will be subject to an additional $100 monthly fee.

Our healthcare provider will assess your medical history, weight loss goals, and BMI to determine your eligibility for the treatment.

The most common side effects may include:

• Gastrointestinal issues: Nausea, diarrhea, vomiting, constipation, and abdominal pain are quite common, especially when starting the medication or after a dose increase.
• Reduced appetite: Many people experience a decrease in hunger, which can contribute to weight loss.
• Hypoglycemia: In some cases, especially when used with other glucose-lowering medications, tirzepatide can cause low blood sugar levels.
• Injection site reactions: Redness, itching, or swelling at the site of injection may occur.
• Fatigue: Some individuals might feel unusually tired.

It's important to monitor for these side effects and discuss any concerns with a healthcare provider, who can provide guidance on managing them or adjust the treatment plan if necessary.

When using tirzepatide for the treatment of weight loss, it's essential to be aware of some important safety information to ensure its safe and effective use:

• Hypoglycemia: Tirzepatide may lower blood sugar levels, especially when combined with other diabetes medications like insulin or sulfonylureas. Monitor your blood glucose regularly and be aware of the signs of low blood sugar (hypoglycemia).
• Gastrointestinal issues: Common side effects of tirzepatide include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain. These effects are generally mild to moderate and often decrease over time. However, if symptoms persist or worsen, consult your healthcare provider.
• Allergic reactions: Although rare, allergic reactions to tirzepatide are possible. If you experience symptoms such as rash, itching, or difficulty breathing, seek immediate medical attention.
• Kidney function: In some cases, tirzepatide may affect kidney function. If you have a history of kidney disease or notice any signs of kidney problems (e.g., changes in urine output, swelling in your legs or feet), inform your healthcare provider.
• Pregnancy and breastfeeding: The safety of tirzepatide during pregnancy and breastfeeding is not well-established. Discuss the potential risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.
• Drug interactions: Tirzepatide may interact with other medications, affecting their efficacy or increasing the risk of side effects. Inform your healthcare provider of all medications you are taking, including prescription, over-the-counter, and herbal supplements.

This list is not exhaustive, and it's crucial to discuss any medical conditions or concerns with your healthcare provider before starting tirzepatide. Always follow your healthcare provider's instructions for using the medication and promptly report any side effects or concerns.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf